You are using an unsupported browser. Please upgrade your browser to a newer version to get the best experience on DrugBank.
Also known as: Acne / Acnes / Acne, unspecified / [X]Acne, unspecified / Acne NOS
DrugDrug NameDrug Description
DB09096Benzoyl peroxideBenzoyl peroxide (BPO) is an organic compound in the peroxide family. It consists of two benzoyl groups bridged by a peroxide link. It is one of the most important organic peroxides in terms of applications. In medicine, benzoyl peroxide is used as a topical treatment for acne, either in combination with antibiotics or as a single agent. These products are available over-the-counter or by prescription in gels, creams or liquids at concentrations of 2.5%, 5% or 10%. Benzoyl peroxide is also used for bleaching flour or hair, teeth whitening, for cross-linking polyester resins, and many other chemical uses. It is on the World Health Organization's List of Essential Medicines, the most important medications needed in a basic health system.
DB00936Salicylic acidA compound obtained from the bark of the white willow and wintergreen leaves, and also prepared synthetically. It has bacteriostatic, fungicidal, and keratolytic actions. Its salts, the salicylates, are used as analgesics.
DB09353SulfurSulfur is a chemical element that is present in all living tissues. After calcium and phosphorus, it is the third most abundant mineral in the human body. Sulfur is also found in garlic, onions and broccoli. People take sulfur by mouth for shortness of breath, allergies, swelling in the back of the throat (pharyngitis), high cholesterol, clogged arteries, menopause, and upper respiratory tract infections like the common cold. Sulfur seems to have an antibacterial activity. It has been also used for acne.
DB05294VandetanibVandetanib is an oral once-daily kinase inhibitor of tumour angiogenesis and tumour cell proliferation with the potential for use in a broad range of tumour types. On April 6 2011, vandetanib was approved by the FDA to treat nonresectable, locally advanced, or metastatic medullary thyroid cancer in adult patients.
DrugDrug NamePhaseStatusCount
DB00982Isotretinoin1Completed1
DB00799Tazarotene1Recruiting1
DB04980Lemuteporfin1 / 2Completed1
DB05676Apremilast2Terminated1
DB00207Azithromycin2Unknown Status1
DB00254Doxycycline2Unknown Status1
DB00254Doxycycline2 / 3Unknown Status1
DB00848Levamisole2 / 3Completed1
DB00210Adapalene3Completed3
DB09096Benzoyl peroxide3Completed4
DB01190Clindamycin3Completed3
DB00250Dapsone3Completed1
DB00254Doxycycline3Completed1
DB00982Isotretinoin3Completed1
DB00755Tretinoin3Completed4
DB00210Adapalene4Active Not Recruiting1
DB00210Adapalene4Completed1
DB09096Benzoyl peroxide4Completed1
DB01190Clindamycin4Completed1
DB01190Clindamycin4Unknown Status1
DB00250Dapsone4Recruiting2
DB00254Doxycycline4Completed1
DB00982Isotretinoin4Active Not Recruiting1
DB01017Minocycline4Completed1
DB00936Salicylic acid4Active Not Recruiting1
DB00936Salicylic acid4Completed1
DB00755Tretinoin4Completed1
DB00210AdapaleneNot AvailableCompleted1
DB00548Azelaic AcidNot AvailableUnknown Status1
DB09096Benzoyl peroxideNot AvailableCompleted1
DB01395DrospirenoneNot AvailableCompleted1
DB00977Ethinyl EstradiolNot AvailableCompleted1
DB00982IsotretinoinNot AvailableCompleted1
DB00755TretinoinNot AvailableActive Not Recruiting1
DB00620TriamcinoloneNot AvailableActive Not Recruiting1